Bristol Myers Squibb BMY announced that it has obtained a positive opinion from the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency for two of its drugs. The ...

Biogen and Eisai said they believe that EC's requests can be addressed with existing information, and that no new safety signals have been identified for Leqembi. The U.S. Food and Drug Administration ...

Squibb announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended ...

X4 Pharmaceuticals (XFOR) announced that its Marketing Authorization Application for mavorixafor for the treatment of WHIM syndrome, a rare ...

Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome ...

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India ...

But most medicinal cannabis products are not officially approved for medical use by the Therapeutic Goods Administration (TGA), Australia’s medicines regulator. These “unapproved” medical ...

Product development is an important area in financial services and it's specifically crucial when it comes to investment management. Determining what asset management fund products will be ...

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China ...

Top exported items include nuclear reactors, boilers, machinery and mechanical appliances, electrical machinery, equipment and parts, chemicals and pharmaceutical products. *Sanctions teams from ...

In a strategic move beyond traditional crops, ITC Limited is exploring avenues in the medicinal and aromatic products segment to focus on value-added agriculture. Leveraging its proven backend ...

The Cyber Trust Mark label, which will appear on smart products sold in the United States later this year, will help American consumers determine whether the devices they want to buy are safe to ...